Acquiring Company
SAI Parenterals Limited
Acquired Company
Prathyak Laboratories Private Limited
HyderabadHyderabadManufacturingBiotechnologyPharmaceuticalBiotechnologyPharmaceuticalDescription
Sai Parenterals Limited has finalized the acquisition of a 60% equity stake in Prathyak Laboratories for ₹15 crore. This strategic move allows Sai Parenterals to bypass construction risks and gain immediate access to an operational R&D facility. Prathyak Laboratories provides specialized capabilities in drug development that enhance Sai Parenterals' growth strategy. The acquisition strengthens their international expansion efforts, particularly focusing on regulatory compliance for global markets.
Fundz sees it the moment SAI Parenterals Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Prathyak Laboratories Private Limited?
Prathyak Laboratories Private Limited was acquired by SAI Parenterals Limited, based in Hyderabad. The deal was reported on October 5, 2026. SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms. Founded in 2005, the company has been expanding its capabilities and market reach. SAI Parenterals Limited is privately held and operates in Manufacturing.
When did SAI Parenterals Limited acquire Prathyak Laboratories Private Limited?
SAI Parenterals Limited's acquisition of Prathyak Laboratories Private Limited was reported on October 5, 2026. Sai Parenterals Limited has finalized the acquisition of a 60% equity stake in Prathyak Laboratories for ₹15 crore. This strategic move allows Sai Parenterals to bypass construction risks and gain immediate access to an operational R&D facility. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Prathyak Laboratories Private Limited do?
Prathyak Laboratories Private Limited is a pharmaceutical research and development platform specializing in complex injectables. The company has a strong pipeline with 150 SKUs across 86 molecules. It offers proven expertise in advanced drug delivery systems. It is privately held, operating in Biotechnology, and is based in Hyderabad.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.